Time Restricted Eating for Metabolic and Psychological Optimization
NCT ID: NCT05997316
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2023-08-07
2025-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults
NCT02970188
The Effects of Diet on Mood, Cognition and Appetite
NCT01201616
Time-restricted Eating in Peri- and Postmenopausal Women
NCT06188598
Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults
NCT04916730
Metabolic Impact of Time Restricted Feeding
NCT03129581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time restricted eating
Participants will engage in a 12-week time restricted fasting intervention. Each week, participants will work with a clinical psychologist to modify the timing of their eating behaviors to adhere to a 16-hour fast, 2-3 days per week.
Time restricted eating
Participants will work with a psychologist towards achieving a 16 hour fasting period, 2-3 days per week. The intervention will last 12 weeks, with different intervention materials gradually introduced over the course of the 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time restricted eating
Participants will work with a psychologist towards achieving a 16 hour fasting period, 2-3 days per week. The intervention will last 12 weeks, with different intervention materials gradually introduced over the course of the 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 65-80 years,
* with amnestic Mild Cognitive Impairment (Montreal Cognitive Assessment Battery score \[MoCA\] total score 19-25; and score of \> 1.0 on the Mail-in Cognitive Function Screening Instrument),
* obese (body mass index 30-40 kg/m\^2),
* sedentary, and
* willing to participate in all aspects of the proposed intervention.
Exclusion Criteria
* secondary causes of obesity,
* evidence of clinical dementia (MoCA score \< 18), severe chronic kidney disease (eGFR \<45 ml/min/1.73m\^2),
* heart failure,
* high grade arrhythmias,
* severe valvular heart disease,
* severe asthma or chronic obstructive lung disease,
* diabetes requiring insulin,
* musculoskeletal or neurologic problems that would preclude participation in aerobic exercise training,
* a major psychiatric disorder,
* a history of drug abuse,
* alcohol consumption \>14 drinks/week,
* gastric bypass surgery,
* non-English speaking, or
* a life-limiting comorbid medical condition (e.g. cancer).
65 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
National Institute on Aging (NIA)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick J Smith, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-2774
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.